NO20075726L - Fremgangsmate for syntese av 6-alkylaminokinolinderivater - Google Patents

Fremgangsmate for syntese av 6-alkylaminokinolinderivater

Info

Publication number
NO20075726L
NO20075726L NO20075726A NO20075726A NO20075726L NO 20075726 L NO20075726 L NO 20075726L NO 20075726 A NO20075726 A NO 20075726A NO 20075726 A NO20075726 A NO 20075726A NO 20075726 L NO20075726 L NO 20075726L
Authority
NO
Norway
Prior art keywords
present
alkylaminoquinoline
synthesis
derivatives
formula
Prior art date
Application number
NO20075726A
Other languages
English (en)
Norwegian (no)
Inventor
Allan Wissner
Mary Carolyn Discafani-Marro
Warren Chew
Sridhar Krishna Rabindran
John Patrick Ii Mcginnis
Youchu Wang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20075726L publication Critical patent/NO20075726L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20075726A 2005-05-25 2007-11-09 Fremgangsmate for syntese av 6-alkylaminokinolinderivater NO20075726L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68504005P 2005-05-25 2005-05-25
PCT/US2006/015931 WO2006127203A2 (en) 2005-05-25 2006-04-26 Methods of synthesizing 6-alkylaminoquinoline derivatives

Publications (1)

Publication Number Publication Date
NO20075726L true NO20075726L (no) 2008-02-04

Family

ID=36794434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075726A NO20075726L (no) 2005-05-25 2007-11-09 Fremgangsmate for syntese av 6-alkylaminokinolinderivater

Country Status (20)

Country Link
US (1) US20060270670A1 (zh)
EP (1) EP1883630A2 (zh)
JP (1) JP2008542266A (zh)
KR (1) KR20080016604A (zh)
CN (1) CN101180273A (zh)
AR (1) AR054192A1 (zh)
AU (1) AU2006249596A1 (zh)
BR (1) BRPI0610142A2 (zh)
CA (1) CA2608589A1 (zh)
CR (1) CR9545A (zh)
GT (1) GT200600215A (zh)
IL (1) IL187301A0 (zh)
MX (1) MX2007014774A (zh)
NO (1) NO20075726L (zh)
PA (1) PA8676301A1 (zh)
PE (1) PE20070007A1 (zh)
RU (1) RU2007140957A (zh)
TW (1) TW200716556A (zh)
WO (1) WO2006127203A2 (zh)
ZA (1) ZA200710143B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135499A1 (en) * 2005-07-11 2007-06-14 Aerie Pharmaceuticals, Inc. Hydrazide compounds
US7470787B2 (en) * 2005-07-11 2008-12-30 Aerie Pharmaceuticals, Inc. Isoquinoline compounds
CA2664335C (en) 2006-09-20 2014-12-02 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
ES2672624T3 (es) * 2009-05-01 2018-06-15 Aerie Pharmaceuticals, Inc. Inhibidores de mecanismo doble para el tratamiento de enfermedades
JP5622842B2 (ja) 2009-05-14 2014-11-12 コーロン ライフ サイエンス インク アルキルアミン誘導体の製造方法
KR101916481B1 (ko) 2010-09-29 2018-11-07 인터벳 인터내셔널 비.브이. N-헤테로아릴 화합물
WO2012041872A1 (en) 2010-09-29 2012-04-05 Intervet International B.V. N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
CN102649778A (zh) * 2011-02-23 2012-08-29 苏州波锐生物医药科技有限公司 喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
EP2833886B1 (en) * 2012-04-04 2020-08-12 HangzhouDeRenYuCheng Biotechnology Ltd. Substituted quinolines as bruton's tyrosine kinase inhibitors
PL3811943T3 (pl) 2013-03-15 2023-06-12 Aerie Pharmaceuticals, Inc. Związek do stosowania w leczeniu zaburzeń oczu
TWI609012B (zh) 2013-04-28 2017-12-21 廣東東陽光藥業有限公司 氨基喹唑啉類衍生物及其鹽和使用方法
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
EP3376870B1 (en) 2015-11-17 2021-08-11 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
PL3447051T3 (pl) * 2016-04-28 2022-03-14 Jiangsu Hengrui Medicine Co., Ltd. Sposób otrzymywania inhibitora kinazy tyrozynowej i jego pochodnej
JP6907319B2 (ja) 2016-08-31 2021-07-21 アエリエ ファーマシューティカルズ インコーポレイテッド 眼科用組成物
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6288082B1 (en) * 1998-09-29 2001-09-11 American Cyanamid Company Substituted 3-cyanoquinolines
US6297258B1 (en) * 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
MXPA02008836A (es) * 2000-03-13 2003-02-10 American Cyanamid Co Uso de cianoquinolinas para tratar o inhibir los polipos colonicos.
UA77200C2 (en) * 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
JP4361375B2 (ja) * 2002-02-05 2009-11-11 ワイス N−アシル−2−アミノ−4−アルコキシ−5−ニトロ安息香酸の合成方法
CL2004000016A1 (es) * 2003-01-21 2005-04-15 Wyeth Corp Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
RU2345069C2 (ru) * 2003-08-19 2009-01-27 Уайт Холдингз Корпорейшн Способ получения 4-амино-3-хинолинкарбонитрилов
RU2006127414A (ru) * 2004-01-16 2008-02-27 Вайет (Us) Хинолиновые промежуточные соединения ингибиторов рецептора тирозинкиназы и их синтез

Also Published As

Publication number Publication date
PA8676301A1 (es) 2009-03-31
CR9545A (es) 2008-01-10
ZA200710143B (en) 2008-11-26
TW200716556A (en) 2007-05-01
RU2007140957A (ru) 2009-06-27
IL187301A0 (en) 2008-04-13
BRPI0610142A2 (pt) 2011-01-04
KR20080016604A (ko) 2008-02-21
US20060270670A1 (en) 2006-11-30
AU2006249596A1 (en) 2006-11-30
PE20070007A1 (es) 2007-02-12
MX2007014774A (es) 2008-02-19
WO2006127203A2 (en) 2006-11-30
JP2008542266A (ja) 2008-11-27
EP1883630A2 (en) 2008-02-06
WO2006127203A3 (en) 2007-05-03
GT200600215A (es) 2006-12-26
AR054192A1 (es) 2007-06-06
CN101180273A (zh) 2008-05-14
CA2608589A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20075726L (no) Fremgangsmate for syntese av 6-alkylaminokinolinderivater
WO2006034833A1 (en) Cyclic diarly ureas suitable as tyrosine kinase inhibitors
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
NO20060314L (no) Nicotinamid-derivater anvendbare som PDE4-inhibitorer
NO20051146L (no) Fremgangsmate for fremstilling av mellomprodukter nyttige for fremstilling av tubulininhibitorer
NO20076000L (no) Aminosyrederivater
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
ATE432930T1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
BR0205683A (pt) Processo para a preparação de derivados de piperazina, e, mesilato de um composto
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
MY139382A (en) New derivatives of artemisinin , and their uses in the treatment of malaria
PL362126A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
NO20033049L (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
PL353291A1 (en) Novel compounds, method of obtaining them, their application as pigments and composition containing them
NO20031137L (no) Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av kiraleforbindelser under betingelsene for en 1,4-Michael-addisjon.Oppfinnelsen angårogså de tilsvarende forbindelser
HUP0401895A2 (hu) Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TH83171A (th) วิธีการของการสังเคราะห์อนุพันธ์ 6-แอลคิลอะมิโนควิโนลีน
DK1406865T3 (da) Ravsyrederivater
HUP0401921A2 (hu) Közbenső termékek mirtazapin előállítására és az előállításukra szolgáló eljárások
HUP0203421A2 (hu) Eljárás 10,11-metanobenzoszuberán-származékok előállítására, valamint a közbenső termékként alkalmazott vegyületek és ezek előállítására szolgáló eljárások
TH83171B (th) วิธีการของการสังเคราะห์อนุพันธ์ 6-แอลคิลอะมิโนควิโนลีน
CY1107483T1 (el) Παραγωγα πυριδαζινης, η χρηση τους ως φαρμακευτικα σκευασματα και η διαδικασια παρασκευης τους

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application